EUVIMEDEUVIMED entdecken
Open Access

Nrf2 sensitizes ferroptosis through L-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease

Caixia Xi, Junfeng Pang, Wenbo Zhi iD, Chang-Sheng S Chang, Umapathy Siddaramappa, Huidong Shi, Anatoli Horuzsko iD, Betty S Pace, Xingguo Zhu iD

Blood Journal · 2023

DOI: 10.1182/blood.2022018159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Journal, 2023. Verfasst von Caixia Xi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Georgia Cancer Center, Augusta University, Augusta, GA. Hauptthemen laut MEDLINE: Ferroptosis, Glutarates, NF-E2-Related Factor 2, Anemia, Sickle Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD) is a chronic hemolysis, constant oxidative stress, and systemic hypoxia condition, and undergoes significant metabolic alterations. However, little is known about the correlation between metabolic alterations and those pathophysiological symptoms. Here we report that Nrf2, a master regulator of cellular antioxidant responses, regulates the production of the metabolite L-2-hydroxyglutarate (L2HG) to mediate epigenetic histone hypermethylation for gene expression involved in metabolic, oxidative and ferroptosis stress responses in SCD. Mechanistically, Nrf2 was found to regulate the expression of L-2-hydroxyglutarate dehydrogenase (L2hgdh) to mediate L2HG production under hypoxia. Gene expression profile analysis indicates that reactive oxygen species (ROS) and ferroptosis response are the most significantly affected signaling pathways after Nrf2 ablation in SCD. Nrf2 silencing and L2HG supplementation sensitize human sickle erythroid cells to the ROS and ferroptosis stresses. The absence of Nrf2 and accumulation of L2HG significantly affect histone methylation for chromatin structure modification and reduce the assembly of transcription complexes on downstream target genes to regulate ROS and ferroptosis responses. Furthermore, pharmacological activation of Nrf2 was found to render protective effects against ROS and ferroptosis stresses in SCD mice. Our data suggest a novel mechanism by which Nrf2 regulates L2HG levels to mediate SCD severity through ROS and ferroptosis stress responses and targeting Nrf2 is a viable therapeutic strategy to ameliorate SCD symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisGlutaratesNF-E2-Related Factor 2Anemia, Sickle CellChromatinEpigenesis, GeneticMethylationAlcohol OxidoreductasesAnimalsMiceReactive Oxygen SpeciesTranscription, GeneticGene Expression Profiling

Substanzen

alpha-hydroxyglutarateGlutaratesNF-E2-Related Factor 2ChromatinAlcohol OxidoreductasesReactive Oxygen Species

Autor:innen und Institutionen

  • Georgia Cancer Center, Augusta University, Augusta, GA.
  • Center for Biotechnology and Genomic Medicine, Consolidated Proteomics and Mass Spectrometry Core Lab, Augusta University, Augusta, GA.
  • Bioinformatics Shared Resource and Integrated Genomics, Georgia Cancer Center, Augusta University, Augusta, GA.
  • Division of Hematology/Oncology, Department of Pediatrics, Augusta University, Augusta, GA.

ORCID-Profile: Wenbo Zhi, Anatoli Horuzsko, Xingguo Zhu

Förderung

  • NIDDK NIH HHS
  • NIH HHS

Zitieren

APA

Xi, C., Pang, J., Zhi, W., Chang, C. S., Siddaramappa, U., Shi, H., Horuzsko, A., Pace, B. S., & Zhu, X. (2023). Nrf2 sensitizes ferroptosis through L-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease. Blood Journal. https://doi.org/10.1182/blood.2022018159

Vancouver

Xi C, Pang J, Zhi W, Chang CS, Siddaramappa U, Shi H, et al. Nrf2 sensitizes ferroptosis through L-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease. Blood Journal. 2023. doi:10.1182/blood.2022018159

BibTeX
@article{Xi2023,
  author = {Xi, Caixia and Pang, Junfeng and Zhi, Wenbo and Chang, Chang-Sheng S and Siddaramappa, Umapathy and Shi, Huidong and Horuzsko, Anatoli and Pace, Betty S and Zhu, Xingguo},
  title = {Nrf2 sensitizes ferroptosis through L-2-hydroxyglutarate-mediated chromatin modifications in sickle cell disease},
  journal = {Blood Journal},
  year = {2023},
  doi = {10.1182/blood.2022018159}
}
Kostenlos starten →